Does VOXELOTOR Cause Mobility decreased? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Mobility decreased have been filed in association with VOXELOTOR (OXBRYTA). This represents 0.0% of all adverse event reports for VOXELOTOR.
6
Reports of Mobility decreased with VOXELOTOR
0.0%
of all VOXELOTOR reports
0
Deaths
4
Hospitalizations
How Dangerous Is Mobility decreased From VOXELOTOR?
Of the 6 reports, 4 (66.7%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VOXELOTOR. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does VOXELOTOR Cause?
Sickle cell anaemia with crisis (11,023)
Product dose omission issue (5,122)
Diarrhoea (3,173)
Off label use (2,364)
Nausea (2,003)
Headache (1,683)
Abdominal pain upper (1,165)
Pain (1,059)
Therapy cessation (1,038)
Fatigue (1,004)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which VOXELOTOR Alternatives Have Lower Mobility decreased Risk?
VOXELOTOR vs VUTRISIRAN
VOXELOTOR vs VX-770
VOXELOTOR vs VX-950
VOXELOTOR vs VYVANSE
VOXELOTOR vs WARFARIN